Aggression and violence in the workplace remains a potential threat to any organization, and as such, must be included in the risk mitigation element of your business continuity planning process.
Steven M. Crimando, MA, CHS III, a contributing writer to this website, offers us an insight into a new “Legal” designer drug — (e.g. the chemical MDVP or methylenedioxypyrovalerone) — that has now been associated with instances of Type III (co-worker to co-worker) violence.
As Mr. Crimando points out in this referenced article, “…just as some psychiatric disorders are more highly correlated with violence, so are certain drugs…. Workplace violence is a constantly evolving operational risk. It is important that anyone concerned with this issue remain current and aware of factors in the organization, the community, and the culture that influences the prevalence and dynamics of violence. With national exposure of this risk by television, radio and print news outlets, the relationship between MDPV and violence will likely be viewed as a “foreseeable” risk sometime soon. This is a curve you will definitely want to stay ahead of….”
Clearly we agree with the position stated by Mr. Crimando, and, if applicable, we ask that you pass this article and information along to those risk management, disaster preparedness and human resource, or even PS-Prep strategy planning team members in your organization.
Click here to read the full article.